Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576874 · ClinicalTrials.gov registry record · NA
The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking
A NA study of Nicotine Dependence, sponsored by Kevin Gray, MD.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT01576874 is a NA study of Nicotine Dependence that has completed, run by Kevin Gray, MD. The registered enrollment target is 144 participants, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01576874, a NA study of Nicotine Dependence, has completed, sponsored by Kevin Gray, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the overall parent study is to determine the impact of gender and hormones (estradiol, progesterone, testosterone and cortisol) on responses to stress and smoking cues presented in daily, "real-world" cue presentations compared to a final cue session in a lab. In addition, in the portion of the study that incorporates clinical trials elements and is reported here, the study will examine the impact of a single dose of oxytocin (chemical produced in the body) versus placebo (inactive substance) on reactivity to a stress procedure (Trier Social Stress Task) in smokers. The overall parent study involves a cue presentation technology known as "CREMA" (Cue Reactivity Ecologic Momentary Assessment) which delivers four daily cue presentations to you on a handheld device during your everyday routine. Additionally, the study involves daily collection of saliva samples for hormonal testing. These daily procedures will provide information about the role of cues and hormones in daily life. The clinical trial portion of the study (reported here) consists of measures collected within the laboratory.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Oxytocin
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2012-06 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576874
The ClinicalTrials.gov registry entry for NCT01576874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (22% lower). The listed sponsor is Kevin Gray, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01576874 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01576874 about?
NCT01576874 is a clinical study titled "The Gender-Sex Hormone Interface With Craving & Stress-Related Changes in Smoking". The purpose of the overall parent study is to determine the impact of gender and hormones (estradiol, progesterone, testosterone and cortisol) on responses to stress and smoking cues presented in daily, "real-world" cue presentations compared to a final cue session in a lab. In addition, in the port...
What is the current status of trial NCT01576874?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2012-06. Estimated completion is 2017-06.
What conditions does trial NCT01576874 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT01576874?
The interventions under investigation include: placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01576874?
This trial is sponsored by Kevin Gray, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01576874 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.